The global oscillating positive expiratory pressure (OPEP) device market is experiencing significant growth, with recent analyses projecting its valuation to reach USD 151.30 million by the end of 2024. This momentum is anticipated to continue, with forecasts indicating a substantial increase to USD 263.40 million by 2034, reflecting a steady Compound Annual Growth Rate (CAGR) of 5.70% during the forecast period.
OPEP devices are becoming indispensable tools in respiratory therapy, designed to assist patients in clearing mucus from their lungs. The increasing adoption of these devices is primarily driven by the rising prevalence of chronic respiratory conditions, including chronic obstructive pulmonary disease (COPD) and asthma. Furthermore, advancements in respiratory therapy technologies are significantly bolstering the demand for these devices, which have proven to enhance patient outcomes and quality of life.
As healthcare systems worldwide emphasize effective respiratory treatments, the demand for innovative solutions like OPEP devices is set to surge. “The OPEP device market is experiencing steady growth, fueled by increased awareness of respiratory health, rising incidence of respiratory diseases, and innovations in medical system infrastructure. The growing demand for respiratory therapy solutions underscores the market’s investment potential,” stated an analyst at Future Market Insights (FMI).
Regional Outlook:
Currently, North America and Europe dominate the OPEP device market, benefiting from well-established healthcare infrastructures and heightened awareness of respiratory therapies. However, East Asia is projected to emerge as a lucrative market from 2024 to 2034, driven by increased local production and the availability of more affordable products. The growing prevalence of COPD, largely due to smoking in China, along with rising respiratory illnesses among the elderly in Japan, are key contributors to this regional expansion.
Despite this positive growth outlook, the market faces challenges, particularly the low awareness of OPEP devices among healthcare practitioners and patients in certain regions. Addressing this knowledge gap will be crucial for unlocking the market’s full potential.
With a robust trajectory ahead, the OPEP device market is well-positioned for significant growth, driven by the escalating need for effective respiratory therapies and technological advancements that enhance patient care.
Key Takeaways:
- The Oscillating Positive Expiratory Pressure (OPEP) Device Market is expected to hold a 33.70% share in the indication category by 2024.
- Mouthpiece PEP devices are projected to dominate with a 96.80% market share in 2024.
- Italy’s OPEP device market is set to grow at a CAGR of 5.20% from 2024 to 2034.
- Germany and China are leading with CAGRs of 5.60% and 6.00%, respectively, through 2034.
- The United States and Japan are also expected to see significant growth, with CAGRs of 5.40% and 5.60%, respectively.
Get the Latest on Oscillating Positive Expiratory Pressure (OPEP) Device: Our Full Report Highlights Key Trends and Insights!
Competitive Landscape:
The OPEP device market is highly competitive, with several key players engaged in strategic partnerships and new product launches to capture market share. Notable developments include:
- Smith’s Medical launched the Acapella Choice Blue vibratory PEP therapy system in April 2021.
- AirPhysio received FDA approval in January 2021 for its Positive Expiratory Pressure (PEP) Device.
Essential Oscillating Positive Expiratory Pressure (OPEP) Device Manufacturers:
- Smith’s Medical, Inc.
- Allergan plc
- Monaghan Medical Corporation & Trudell Medical International
- PARI GmbH
- WyMedical Pty Ltd
- R. Cegla GmbH & Co. KG
- D-R BURTON HEALTHCARE
- AirPhysio
- Medica Holdings, LLC.
Key Segments:
- By Product Type: Face Mask PEP Devices, Mouthpiece PEP Devices, Bottle PEP Devices
- By Indication: COPD, Asthma, Atelectasis, Bronchitis, Bronchiectasis, Cystic Fibrosis, Others
- By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
- By Region: North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube